In 2023, Vertex Pharmaceuticals conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Vertex Pharmaceuticals generated a total of 1,689 metric tonnes of waste.
Of this amount, 30.95% of Vertex Pharmaceuticals's total waste generated was recovered through methods such as recycling, reuse, or composting, while 69.05% was disposed of through landfilling, incineration, or combustion.
In 2023, Vertex Pharmaceuticals reported a total waste generation of 1,689 metric tonnes, of which 30.95% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Vertex Pharmaceuticals is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Since 2021, Vertex Pharmaceuticals's total waste generation increased by 51.92%, including a 29.12% increase in 2023, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.
Over the same period, Vertex Pharmaceuticals's waste recovery rate remained relatively flat, but declined by 12.3% in 2023, potentially pointing to emerging inefficiencies or short-term disruptions in recovery efforts.
Overall, Vertex Pharmaceuticals’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.
In 2023, Vertex Pharmaceuticals generated a total of 1,689 metric tonnes of waste.
Of this amount, 28.24% of Vertex Pharmaceuticals's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 71.76% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2021, Vertex Pharmaceuticals's total waste generation increased by 51.92%, including a 29.12% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, Vertex Pharmaceuticals reduced the hazardousness of its waste by 19.03%, with a further 13.88% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.
Overall, Vertex Pharmaceuticals is generating more waste but has significantly reduced the share of hazardous materials, suggesting a partial decoupling of volume and toxicity that could reflect more responsible inputs or enhanced treatment.
In 2023, Vertex Pharmaceuticals reported that 477 metric tonnes of its total waste output were classified as hazardous. This represents 28.24% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. Approximately 25.08% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.